Can anything be done to get an efficacy signal for seniors quickly?

My last post was pretty much a downer but I have been thinking about it more and there is a way to fix the problem if we act quickly: enlarge the trials with more seniors no matter what the cost and difficulty to do so. More later.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.